情報リーフレット
FLUVIRIN
®
CMI
FLU_CMI_26Nov2010
Page 1 of 5
CONSUMER MEDICINE INFORMATION
FLUVIRIN
®
2011
INACTIVATED INFLUENZA VACCINE (SURFACE ANTIGEN)
WHAT IS IN THIS
LEAFLET
This leaflet answers some common
questions about Fluvirin
®
vaccine.
It does not contain all the available
information.
It does not take the place of talking
to your doctor or pharmacist.
All medicines, including vaccines,
have risks and benefits. Your
doctor considers the risks of you or
your child having Fluvirin
®
vaccine
and the benefits he/she expect it
will have.
IF YOU HAVE ANY CONCERNS ABOUT
THIS VACCINE, ASK YOUR DOCTOR,
NURSE OR PHARMACIST.
KEEP THIS LEAFLET.
You may need to read it again.
WHAT FLUVIRIN
®
VACCINE IS USED FOR
Fluvirin
®
vaccine helps prevent
influenza, often called the flu.
Influenza is caused by infection
with specific influenza viruses.
New types of influenza virus can
appear each year. Fluvirin
®
vaccine
contains strains of three different
types of influenza virus. Each year
the Australian Influenza Vaccine
Committee and the New Zealand
Ministry of Health decide which
three types of virus are most
suitable.
Vaccination against influenza
helps prevent infection with
influenza and to control the
spread of the disease.
The virus in the vaccine is
inactivated. Therefore the
vaccine will not give you or your
child the flu.
Note: the vaccine will not
protect you or your child from
the other influenza viruses that
Fluvirin
®
vaccine does not
contain. It will not protect you
from other types of influenza
virus or from infections with
other agents causing flu-like
symptoms (such as the common
cold).
Fluvirin
®
vaccine is available
only with a doctor's prescription.
This year (2011) the viruses are
A/California/7/2009
(H1N1)
完全なドキュメントを読む
製品の特徴
FLU_PI_26Nov2010
1/5
FLUVIRIN
®
2011
PRODUCT INFORMATION
NAME OF THE MEDICINE
FLUVIRIN
®
[lnactivated Influenza Vaccine (Surface Antigen) Ph. Eur.].
FLUVIRIN
®
contains purified
haemagglutinin and neuraminidase surface
antigens prepared from influenza viruses currently recommended
by the Australian Influenza Vaccine Committee (AIVC)
DESCRIPTION
FLUVIRIN
®
[inactivated influenza vaccine (Surface Antigen) Ph.
Eur.) is a slightly opalescent, sterile solution
for injection. Each 0.5 mL single dose syringe
contains 15 micrograms of each of the purified haemagglutinin
and neuraminidase antigens prepared from the influenza
virus strains currently recommended by the AIVC,
which for the 2011 Winter are:
A/California/07/2009 (H1N1)
– like strain (A/California/07/2009, NYMC X-181);
A/Perth/16/2009 (H3N2)
– like strain (A/Victoria/210/2009, NYMC X-187); and
B/Brisbane/60/2008
– like strain (B/Brisbane/60/2008, NYMC BX-35).
The strains chosen for vaccine manufacture are endorsed by the
AIVC as being antigenically equivalent to the
reference virus.
The vaccine contains the following excipients: water for
injection, sodium phosphate-dibasic, potassium
phosphate-monobasic and sodium chloride.
PHARMACOLOGY
This vaccine is used for active immunisation against influenza
virus, types A and B, principally for the
vaccination of those groups regarded as being at special risk,
especially the elderly.
The vaccine stimulates production of antibodies with a
specific capacity against influenza. Any protection is
only against those strains of the virus from which
the vaccine is prepared or closely related strains.
Studies with surface antigen influenza vaccine have shown that the
purified haemagglutinin and
neuraminidase antigens contained in a single dose of FLUVIRIN
®
[inactivated Influenza Vaccine (Surface
Antigen) Ph. E
完全なドキュメントを読む